Pulmonary Hypertension Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
Conditions: Pulmonary Hypertension; Heart Failure With Reduced Ejection Fraction; Hypertension; Vascular Diseases; Cardiovascular Diseases; Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction Interventions: Procedure: Pulmonary arterial denervation; Drug: Guideline-directed medical therapy (GDMT) for heart failure Sponsors: Pulnovo Medical (Wuxi) Co., Ltd.; The General Hospital of Northern Theater Command; The First Affiliated Hospital with Nanjing Medical University; First Hospital of Tsi...
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Condition: Pulmonary Arterial Hypertension Interventions: Drug: Selexipag; Drug: Riociguat; Device: CardioMEMS pulmonary artery pressure monitor; Device: Confirm Rx Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; University of Glasgow; University of Sheffield; University of Newcastle Upon-Tyne; University of Cambridge Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
Conditions: Pulmonary Hypertension; Heart Failure With Reduced Ejection Fraction; Hypertension; Vascular Diseases; Cardiovascular Diseases; Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction Interventions: Procedure: Pulmonary arterial denervation; Drug: Guideline-directed medical therapy (GDMT) for heart failure Sponsors: Pulnovo Medical (Wuxi) Co., Ltd.; The General Hospital of Northern Theater Command; The First Affiliated Hospital with Nanjing Medical University; First Hospital of Tsi...
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Condition: Pulmonary Arterial Hypertension Interventions: Drug: Selexipag; Drug: Riociguat; Device: CardioMEMS pulmonary artery pressure monitor; Device: Confirm Rx Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; University of Glasgow; University of Sheffield; University of Newcastle Upon-Tyne; University of Cambridge Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
Conditions: Pulmonary Hypertension; Heart Failure With Reduced Ejection Fraction; Hypertension; Vascular Diseases; Cardiovascular Diseases; Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction Interventions: Procedure: Pulmonary arterial denervation; Drug: Guideline-directed medical therapy (GDMT) for heart failure Sponsors: Pulnovo Medical (Wuxi) Co., Ltd.; The General Hospital of Northern Theater Command; The First Affiliated Hospital with Nanjing Medical University; First Hospital of Tsi...
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Condition: Pulmonary Arterial Hypertension Interventions: Drug: Selexipag; Drug: Riociguat; Device: CardioMEMS pulmonary artery pressure monitor; Device: Confirm Rx Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; University of Glasgow; University of Sheffield; University of Newcastle Upon-Tyne; University of Cambridge Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
Conditions: Pulmonary Hypertension; Heart Failure With Reduced Ejection Fraction; Hypertension; Vascular Diseases; Cardiovascular Diseases; Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction Interventions: Procedure: Pulmonary arterial denervation; Drug: Guideline-directed medical therapy (GDMT) for heart failure Sponsors: Pulnovo Medical (Wuxi) Co., Ltd.; The General Hospital of Northern Theater Command; The First Affiliated Hospital with Nanjing Medical University; First Hospital of Tsi...
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Condition: Pulmonary Arterial Hypertension Interventions: Drug: Selexipag; Drug: Riociguat; Device: CardioMEMS pulmonary artery pressure monitor; Device: Confirm Rx Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; University of Glasgow; University of Sheffield; University of Newcastle Upon-Tyne; University of Cambridge Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
Conditions: Pulmonary Hypertension; Heart Failure With Reduced Ejection Fraction; Hypertension; Vascular Diseases; Cardiovascular Diseases; Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction Interventions: Procedure: Pulmonary arterial denervation; Drug: Guideline-directed medical therapy (GDMT) for heart failure Sponsors: Pulnovo Medical (Wuxi) Co., Ltd.; The General Hospital of Northern Theater Command; The First Affiliated Hospital with Nanjing Medical University; First Hospital of Tsi...
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Condition: Pulmonary Arterial Hypertension Interventions: Drug: Selexipag; Drug: Riociguat; Device: CardioMEMS pulmonary artery pressure monitor; Device: Confirm Rx Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; University of Glasgow; University of Sheffield; University of Newcastle Upon-Tyne; University of Cambridge Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
Conditions: Pulmonary Hypertension; Heart Failure With Reduced Ejection Fraction; Hypertension; Vascular Diseases; Cardiovascular Diseases; Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction Interventions: Procedure: Pulmonary arterial denervation; Drug: Guideline-directed medical therapy (GDMT) for heart failure Sponsors: Pulnovo Medical (Wuxi) Co., Ltd.; The General Hospital of Northern Theater Command; The First Affiliated Hospital with Nanjing Medical University; First Hospital of Tsi...
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Condition: Pulmonary Arterial Hypertension Interventions: Drug: Selexipag; Drug: Riociguat; Device: CardioMEMS pulmonary artery pressure monitor; Device: Confirm Rx Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; University of Glasgow; University of Sheffield; University of Newcastle Upon-Tyne; University of Cambridge Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
Conditions: Pulmonary Hypertension; Heart Failure With Reduced Ejection Fraction; Hypertension; Vascular Diseases; Cardiovascular Diseases; Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction Interventions: Procedure: Pulmonary arterial denervation; Drug: Guideline-directed medical therapy (GDMT) for heart failure Sponsors: Pulnovo Medical (Wuxi) Co., Ltd.; The General Hospital of Northern Theater Command; The First Affiliated Hospital with Nanjing Medical University; First Hospital of Tsi...
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
Condition: Pulmonary Arterial Hypertension Interventions: Drug: Selexipag; Drug: Riociguat; Device: CardioMEMS pulmonary artery pressure monitor; Device: Confirm Rx Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; University of Glasgow; University of Sheffield; University of Newcastle Upon-Tyne; University of Cambridge Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
Conditions: Pulmonary Hypertension; Heart Failure With Reduced Ejection Fraction; Hypertension; Vascular Diseases; Cardiovascular Diseases; Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction Interventions: Procedure: Pulmonary arterial denervation; Drug: Guideline-directed medical therapy (GDMT) for heart failure Sponsors: Pulnovo Medical (Wuxi) Co., Ltd.; The General Hospital of Northern Theater Command; The First Affiliated Hospital with Nanjing Medical University; First Hospital of Tsi...
Source: ClinicalTrials.gov - April 24, 2023 Category: Research Source Type: clinical trials
